Pharmazz, Inc. was founded in 2010 and it rapidly established a multi-national collaborative team with facilities and management in the US, UK and India.
Company is focused on therapeutic markets with unmet clinical needs in the area of critical care medicine. It is privately held and the business model of the company is to design, develop, and commercialize novel products.
Pharmazz licensed exclusive worldwide rights to two patent applications from Midwestern University, Downers Grove, Illinois, USA. It has established working partnerships with several organizations and companies in India.
PMZ-2010 (centhaquin) research to be presented at 42nd Critical Care Congress, San Juan, Puerto Rico, January 19-23, 2013
PMZ-2010 (centhaquin) research to be presented at 45th Annual Conference of Indian Pharmacology Society, Nagpur, India, January 5-7, 2013
